Compensation report for the Executive Board and the Supervisory Board of Aurubis AG

The following compensation report is part of the Combined Management Report. It outlines the structure and level of the Aurubis AG’s Executive Board and Supervisory Board compensation.

Compensation for the Executive Board

The Supervisory Board defines the total compensation of the individual Executive Board members on the basis of proposals from the Personnel Committee and decides on and reviews the compensation system for the Executive Board at regular intervals.

In 2017, the Supervisory Board fundamentally revised the compensation system, working together with an independent external compensation expert. The new compensation system complies with the requirements of the German Stock Corporation Act (AktG) and the German Corporate Governance Code, particularly Section 4.2.3 of the German Corporate Governance Code. The participants of the Annual General Meeting approved the new compensation system pursuant to Section 120 (4) of the German Stock Corporation Act (AktG) on March 1, 2018.

Because of the responses of some investors, the Supervisory Board decided to change the composition of the annual bonus. The Supervisory Board passed a resolution on this adjustment on September 11, 2018.

Specifically, as of October 1, 2018, the annual bonus is calculated with a higher weighting of 60 % (previously 50 %) according to the target set for the fiscal year for the operating EBT components, and a lower weighting of 40 % (previously 50 %) according to the assessment of the Executive Board member’s individual performance for the respective fiscal year.

In light of the fundamental revision of the German Corporate Governance Code (DCGK) and the German draft bill on transposing the second EU Shareholder Rights Directive (EU 2017/828, ARUG II), the Supervisory Board is currently refraining from further revision of the compensation system. Both the draft of the German Corporate Governance Code and the German draft bill on transposing EU 2017/828 include extensive regulations on compensation for the advisory bodies of exchange-listed companies. As of now, both the German Corporate Governance Code and the German law on transposing EU 2017/828 are expected to be passed in summer 2019.

Because the compensation system for Executive Board members will have to be reviewed, adjusted, and presented again at the Annual General Meeting anyway due to these developments, the company will refrain from taking a vote on the compensation system at the 2019 Annual General Meeting.

The new compensation system applies to Chief Financial Officer Mr. Rainer Verhoeven and to Chief Operating Officer Dr. Thomas Bünger, the latter of whom was appointed on October 1, 2018. For the Executive Board members Mr. Jürgen Schachler (until June 30, 2019) and Dr. Stefan Boel (Executive Board member until July 31, 2018), the old compensation system applies and will initially continue to apply.

Previous compensation system for the Executive Board

The compensation is defined in the employment contracts and consists of a series of coordinated compensation components.

Specifically, these components are fixed compensation, variable compensation, fringe benefits, and pension plans.

Fixed components
The fixed portion consists of fixed compensation, fringe benefits, and pension plans.

The annual fixed compensation amounts to € 600,000 for the Executive Board Chairman and € 420,000 for ordinary Executive Board members, and is paid out monthly in equal installments.

Additionally, the Executive Board members receive fringe benefits in the form of benefits in kind, which primarily consist of insurance premiums and company car use and are assessed according to tax guidelines.

Mr. Schachler and Dr. Boel receive defined contribution pension plans from the company. Annual contributions of € 140,000 for Mr. Schachler and € 100,000 for Dr. Boel are/were paid to an insurance company.

Both of these Executive Board members additionally have a defined contribution company pension plan. The pension plan is designed as a capital commitment. At the end of every fiscal year, € 120,000 for the Chief Executive Officer and € 80,000 for each ordinary Executive Board member is paid into liability insurances.

The respective Executive Board member can use the accumulated capital after reaching the age of 62 at the earliest – however, not before ceasing to be employed by the company.

Variable components
The old system of variable compensation includes two components, which are paid out annually. The first component (Component I) is dependent on achieving an annual target related to adjusted average consolidated EBT (earnings before taxes) for the Group for three years, and in each case relating to the current fiscal year and to the two fiscal years preceding it. The target is EBT derived from ROCE (return on capital employed) of 15 %. If the EBT is less than 40 % of the target, Component I is not paid. The target bonus from Component I can reach a maximum of 100 % (cap). The maximum amount that can be reached from these components in the case of 100 % target achievement is € 750,000 for the Chief Executive Officer and € 500,000 for each ordinary Executive Board member.

Component II stipulates an annual assessment of the joint (Component II a) and individual (Component II b) performance of the Executive Board by the Supervisory Board. Both components are based on a qualitative, criteria-supported assessment of sustainable company management. The target bonus from Component II can reach a maximum of 100 % (cap). A payout of a minimum of 50 % of the target bonus always occurs unless this is unreasonable within the meaning of Section 87 (2) of the German Stock Corporation Act (AktG). The maximum amount that can be reached from each of the Components II a and II b is € 250,000 for the Chief Executive Officer and € 175,000 for each ordinary Executive Board member.

The target bonus for Component I is 60 % of the total variable compensation; the target bonus for Component II is 40 %.

Premature termination
The employment contracts for the Executive Board members do not contain Change of Control clauses.

Explanation of the new compensation system for the Executive Board

The new compensation system also consists of fixed and variable components. The compensation structure includes maximum limits, both overall and with regard to its variable compensation components. The new compensation system applies to Chief Financial Officer Mr. Verhoeven and to Chief Operating Officer Dr. Bünger, the latter of whom was appointed on October 1, 2018.

The variable compensation components contain annual and multiannual components. The details of the various compensation components are as follows:

Fixed components
The fixed compensation components consist of fixed compensation, pension plans, and fringe benefits.

The annual fixed compensation amounts to € 420,000 for Mr. Verhoeven and is paid out monthly in equal installments.

The pension plans have not changed in comparison with the old compensation system.

Mr. Verhoeven receives an entitlement for the company pension plan in the form of a pension commitment. Aurubis AG’s contribution amounts to € 100,000 per year. The contributions are paid into liability insurances.

Mr. Verhoeven also has a defined contribution company pension plan in the form of a capital commitment. Aurubis AG’s contribution amounts to € 80,000 for him per year. Mr. Verhoeven can use the accumulated capital after reaching the age of 62 at the earliest – however, not before ceasing to be employed by the company.

Additionally, Mr. Verhoeven receives fringe benefits in the form of benefits in kind, which primarily consist of insurance premiums and company car use, and are assessed according to tax guidelines.

At its discretion, the Supervisory Board can grant special compensation for exceptional performance that is not covered by the regular compensation. This is stipulated in the employment contract. However, the total cap may not be exceeded. No special compensation was granted in fiscal year 2017/18. The Supervisory Board most recently granted one-time special compensation in fiscal year 2015/16 for additional interim duties performed in the Executive Board by Dr. Boel and Mr. Faust, the latter of whom served as Executive Board Spokesman until Mr. Schachler filled the vacant position of Executive Board Chairman on July 1, 2016.

Variable components
The system for variable compensation includes both annual variable compensation (annual bonus) and multiannual variable compensation, which is forward-looking. The multiannual, forward-looking variable compensation consists of both a “Performance Cash Plan” over three fiscal years and stock deferred over two fiscal years (virtual stock). The ratio of multiannual to annual variable compensation is 60:40. 

Variable compensation

Chart: Concentrate throughput

Annual bonus
Two-thirds of the annual variable compensation (the annual bonus) is paid out after the end of the fiscal year and amounts to € 272,000 (max. € 340,000) for Mr. Verhoeven in the case of 100 % target achievement. The remaining one-third of the annual bonus is transferred to a virtual two-year stock deferral plan.

Until September 30, 2018, the annual bonus was calculated with a weighting of 50 % according to the target set for the fiscal year for the operating EBT components, and a weighting of 50 % according to the assessment of the individual performance for the respective fiscal year, both multiplied by the target value defined in the Executive Board contract.

Starting October 1, 2018, the annual bonus for Mr. Verhoeven is calculated with a weighting of 60 % according to the target set for the fiscal year for the operating EBT components, and a weighting of 40 % according to the assessment of the Executive Board member’s individual performance for the respective fiscal year, both multiplied by the target value defined in the Executive Board contract. 

Annual bonus operating principle

Target achievement for the operating EBT is determined on the basis of an actual/actual comparison. The actual value of the operating EBT in the respective fiscal year is compared with the actual value of the operating EBT of the fiscal year preceding the current fiscal year (previous year). For an unchanged operating EBT compared to the previous year, the target attainment is 100 %. If the operating EBT is increased by 20 %, the maximum value of 125 % target achievement is reached. For an operating EBT of minus 40 % compared to the previous year, the minimum value of 62.5 % target achievement is reached. Target achievement between these points (62.5 %, 100 %, 125 %) is interpolated in a linear manner. If the maximum value is reached, further increases to the operating EBT do not lead to an additional increase of the target attainment. If the minimum value is not reached, the target attainment is 0 %. If the operating EBT is negative for both the previous year and the respective fiscal year, the Supervisory Board is authorized to set the target attainment according to its discretion. If a positive operating EBT was achieved in the previous year and a negative EBT in the respective fiscal year, the target attainment amounts to 0 %. The annual bonus rewards operating consolidated earnings growth and thereby a strengthening of the company’s profitability as compared with the previous year’s EBT.

Calibrating the performance targets – EBT

Chart: Calibrating the performance targets

Individual performance is evaluated by the Supervisory Board and is based on criteria previously defined in the employment contract. Currently, strategic company development, employees and leadership, and corporate social responsibility are designated as criteria for assessing individual performance. The Supervisory Board can set the degree of target attainment between 0 % and 125 %. Furthermore, the Supervisory Board can, at its discretion, reduce the annual bonus in the event of extraordinary, unforeseeable developments (Section 87 (1) sentence 3 (second half of the sentence) of the German Stock Corporation Act).

The annual bonus stipulates a target value cap of 125 % for Mr. Verhoeven. Therefore, the annual bonus can amount to a maximum of € 510,000.

Two-thirds of the annual bonus is paid out directly after the end of the fiscal year. The last third is paid into the stock deferral, which is explained below. There is also a cap on the deferred stock payout.

Deferred stock
In order to guarantee a focus on stock for the variable compensation, one-third of the annual bonus flows into a virtual stock deferral plan. The stock deferral plan stipulates a two-year, forward-looking assessment basis and amounts to € 136,000 for Mr. Verhoeven in the case of 100 % target attainment.

The number of virtual shares at the beginning of the two-year vesting period is calculated by dividing one-third of the annual bonus by the starting share price. The starting share price is designated by the arithmetic average of the Xetra closing price for Aurubis shares on the Frankfurt Stock Exchange over the last 30 trading days before the beginning of the two-year deferral term.

Deferred stock operating principle

At the end of the two-year term, the number of virtual shares is multiplied by the closing share price. The closing share price also results from the arithmetic average of the Xetra closing price for Aurubis shares on the Frankfurt Stock Exchange over the last 30 trading days, this time before the end of the term. The resulting amount is paid out to the Executive Board members in cash at the end of the two-year term. However, the amount of the payout is limited to 150 % of the initial value (corresponding to one-third of the annual bonus). The payout from the stock deferral plan for Mr. Verhoeven is limited to € 255,000.

Performance Cash Plan
The Performance Cash Plan stipulates a three-year, forward-looking assessment basis. The relevant performance target is the average operating return on capital employed (ROCE) over the three-year period, as identified in the Annual Report. The amount paid out is calculated by multiplying the target set at the end of the three-year period for the operating ROCE by the target value of the Performance Cash Plan specified in the Executive Board contract. The target value currently amounts to € 272,000 for Mr. Verhoeven. The calculated amount to be paid out is limited to 125 % of the target and can therefore reach a maximum of € 340,000. Furthermore, the Supervisory Board can, at its discretion, reduce the Performance Cash Bonus in the event of extraordinary, unforeseeable developments (Section 87 (1) sentence 3 (second half of the sentence) of the German Stock Corporation Act).

In order to determine the final target achievement for the Performance Cash Plan, the average operating ROCE achieved during the period (calculated annually after the respective fiscal years) is calculated at the end of the three-year period. The Supervisory Board determines an amount for 100 % target achievement (“target value”) for the average operating ROCE, as well as amounts for 50 % target achievement (“minimum value”) and 125 % target achievement (“maximum value”). The target value of the average operating ROCE for the three-year time period for the fiscal years from 2017/18 up to and including 2019/20 amounts to 12 %, with the minimum value being 6 % and the maximum value 15 %. The same target values also apply for the next three-year period from 2018/19 up to and including 2020/21. Target achievement between these points (50 %, 100 %, 125 %) is interpolated in a linear manner. If the minimum value is not reached, there is no payout from the Performance Cash Plan. If the maximum value is reached, further increases to the average operating ROCE do not lead to an additional increase of the target achievement. The Performance Cash Plan incentivizes the generation of a positive value contribution by means of an ambitious ROCE target range. The payout takes place at the end of the respective three-year period in cash.

Performance Cash Plan operating principle

Chart: Performance Cash Plan operating principle

Calibrating the performance targets – ROCE

Total cap
In total (fixed and variable components), compensation for Mr. Verhoeven is limited to an amount of € 1,355,000. Fringe benefits and benefit contributions from pension plans do not fall under the total cap.

Premature termination
In the event of a premature termination of an Executive Board position without good cause, a severance payment will be made within the scope of the new compensation system. Such payment is limited to two years’ total annual compensation in accordance with the German Corporate Governance Code recommendations, and does not provide compensation for any period longer than the remaining term of the employment contract. The employment contracts for the Executive Board members do not contain Change of Control clauses.

Amount of compensation for the Executive Board in fiscal year 2017/18

In total, compensation for active Executive Board members for activities in fiscal year 2017/18 amounted to € 3,812,280, including pension expenses (€ 570,000) and expenses for the virtual stock deferral plan (€ 93,149).

Dr. Boel left the company at the close of July 31, 2018 by amicable and mutual agreement with the Supervisory Board. The termination agreement includes the payment of the fixed and variable income components until July 31, 2018. The variable components will be paid out in January 2019. Moreover, Dr. Boel will receive a one-time gross payment of € 1,600,000. The contributions to the defined contribution pension commitment and the defined contribution company pension plan for Dr. Boel were paid proportionally until July 31, 2018.

The company has set up pension provisions on the basis of IFRS for the Executive Board members. In the reporting year, allocations to pension provisions for the active Executive Board members amounted to € 570,000. This amount comprises contributions to an external pension fund.

Former members of the Executive Board and their surviving dependents received a total of € 2,246,373 in fiscal year 2017/18, while € 27,403,439 (in accordance with HGB) and € 32,259,232 (in accordance with IAS) has been provided for their pension entitlements.

Individual details can be found in the following tables:

Benefits granted

in €   Fixed
compensation
Fringe
benefits
Total Variable
compensation
for one year
Variable
compensation
for several years
Variable
compensation
for several years:
deferred stock
Variable
compensation
for several years:
Performance
Cash Plan
Total Pension
expenses 1
Total
compensation
                       
Jürgen Schachler 2016/17 570,000 19,586 589,586 475,000 686,850     1,751,436 260,000 2,011,436
Executive Board Chairman 2017/18 600,000 22,474 622,474 500,000 504,750     1,627,224 260,000 1,862,224
since July 1, 2016 Min. 600,000 22,474 622,474 250,000 0     872,474 260,000 1,132,474
  Max. 600,000 22,474 622,474 500,000 750,000     1,872,474 260,000 2,132,474
Dr. Stefan Boel 2 2016/17 399,000 18,389 417,389 332,500 457,900     1,207,789 180,000 1,387,789
Executive Board member 2017/18 350,000 15,651 365,651 291,667 280,417     937,735 150,000 1,087,735
from April 19, 2008 to July 31, 2018 Min. 350,000 15,651 365,651 145,834 0     511,485 150,000 661,485
  Max. 350,000 15,651 365,651 291,667 416,667     1,073,985 150,000 1,223,985
Rainer Verhoeven 3 2016/17     0         0   0
Executive Board member 2017/18 315,000 10,754 325,754 199,594   99,797 240,720 865,865 160,000 1,025,864
since January 1, 2018 Min. 315,000 10,754 325,754 0   0 0 325,754 160,000 485,754
  Max. 315,000 10,754 325,754 255,000   191,250 255,000 1,027,004 160,000 1,187,004
Total 2016/17 969,000 37,975 1,006,975 807,500 1,144,750     2,959,225 440,000 3,399,225
  2017/18 1,265,000 48,879 1,313,879 991,261 841,250 99,797 240,720 3,430,824 570,000 4,000,824
  Min. 1,265,000 48,879 1,313,879 395,834 0 0 0 1,709,713 570,000 2,279,713
  Max. 1,265,000 48,879 1,313,879 1,046,667 1,166,667 191,250 255,000 3,973,463 570,000 4,543,463
1 Pension expenses in accordance with the German Commercial Code (HGB) amounted to € 150,000 € (previous year: € 180,000) for Dr. Stefan Boel, € 160,000 for Rainer Verhoeven, and € 260,000 (previous year: € 260,000) for Jürgen Schachler.
2 Refers to compensation for the time period from October 1, 2017 to July 31, 2018.
3 Refers to compensation for the time period from January 1, 2018 to September 30, 2018.

Dr. Boel received severance pay of € 1,600,000.
The variable multiannual compensation for fiscal year 2017/18 is determined according to the ratio of the operating actual-to-target EBT relating to the Aurubis Group and the average of the fiscal years 2015/16, 2016/17, and 2017/18.
The average actual EBT is € 280 million and represents a target achievement of 75 %.

Inflow

in €   Fixed
compensation
Fringe
benefits
Total Variable
compensation
for one year
Variable
compensation
for several years
Variable
compensation
for several years:
deferred stock
Variable
compensation
for several years:
Performance
Cash Plan
Total Pension
expenses 1
Total
compensation
                       
Jürgen Schachler 2016/17 570,000 19,586 589,586 475,000 686,850     1,751,436 260,000 2,011,436
Executive Board Chairman
since July 1, 2016
2017/18 600,000 22,474 622,474 475,000 559,500     1,656,974 260,000 1,941,974
Dr. Stefan Boel 2016/17 399,000 18,389 417,389 299,250 460,750     1,177,389 180,000 1,357,389
Executive Board member
from April 19, 2008 to July 31, 2018
2017/18 350,000 15,651 365,651 262,500 310,833     938,984 150,000 1,088,984
Rainer Verhoeven 2016/17 0 0 0 0 0     0 0 0
Executive Board member
since January 1, 2018
2017/18 2 315,000 10,754 325,754 227,419 0 04 0 553,173 160,000 713,173
  2016/17 969,000 37,975 1,006,975 774,250 1,147,600     2,928,825 440,000 3,368,825
Total 2017/18 1,265,000 48,879 1,313,879 964,919 870,333     3,149,131 570,000 3,719,131
1 Pension expenses in accordance with the German Commercial Code (HGB) amounted to € 150,000 € (previous year: € 180,000) for Dr. Stefan Boel, € 160,000 for Rainer Verhoeven, and € 260,000 (previous year: € 260,000) for Jürgen Schachler.
2 Refers to compensation for the time period from October 1, 2017 to July 31, 2018.
3 Refers to compensation for the time period from January 1, 2018 to September 30, 2018.
4 The fair value based on planning data amounts to € 93,149. The subscription right for deferred stock in 2017/18 applies to 1,883 virtual shares.

Dr. Boel received severance pay of € 1,600,000.
The variable multiannual compensation for fiscal year 2017/18 is determined according to the ratio of the operating actual-to-target EBT relating to the Aurubis Group and the average of the fiscal years 2015/16, 2016/17, and 2017/18.
The average actual EBT is € 280 million and represents a target achievement of 75 %.

Compensation for the Supervisory Board

Supervisory Board compensation for fiscal year 2017/18

in €

Name
  Fixed
compensation
Compensation
for committee
membership
Attendance fees Total
           
Prof. Dr. Fritz Vahrenholt 2016/17 75,000 22,500 11,000 108,500
  2017/18 162,945 44,489 17,000 224,434
Renate Hold-Yilmaz 2016/17 150,000 25,000 14,000 189,000
  2017/18 150,000 25,000 18,000 193,000
Andrea Bauer 2016/17        
  2017/18 20,753 1,706 2,000 24,459
Burkhard Becker 2016/17 75,000 22,500 11,000 108,500
  2017/18 31,233 9,370 10,000 50,603
Dr. Bernd Drouven 2016/17 75,000 30,000 11,000 116,000
  2017/18 31,233 12,494 6,000 49,727
Dr.-Ing. Joachim Faubel 2016/17 75,000 0 5,000 80,000
  2017/18 31,233 0 6,000 37,233
Prof. Dr.-Ing. Heinz Jörg Fuhrmann 2016/17 225,000 50,000 12,000 287,000
  2017/18 137,466 46,911 19,000 203,377
Karl-Heinz Hamacher 2016/17        
  2017/18 43,973 8,795 5,000 57,768
Prof. Dr. Karl Friedrich Jakob 2016/17        
  2017/18 43,973 13,192 9,000 66,165
Jan Koltze 2016/17 75,000 15,000 9,000 99,000
  2017/18 75,000 15,000 14,000 104,000
Dr. Stephan Krümmer 2016/17        
  2017/18 43,973 21,986 8,000 73,959
Dr. Elke Lossin 2016/17        
  2017/18 43,973 8,795 7,000 59,768
Dr. Sandra Reich 2016/17 75,000 7,500 5,000 87,500
  2017/18 75,000 11,898 13,000 99,898
Stefan Schmidt 2016/17        
  2017/18 43,973 8,795 8,000 60,768
Edna Schöne 2016/17        
  2017/18 21,986 2,199 1,000 25,185
Dr. med. Dipl.-Chem. Thomas Schultek 2016/17 75,000 22,500 11,000 108,500
  2017/18 31,233 9,370 6,000 46,603
Rolf Schwertz 2016/17 75,000 0 5,000 80,000
  2017/18 31,233 0 6,000 37,233
Melf Singer 2016/17        
  2017/18 43,973 4,397 5,000 53,370
Ralf Winterfeldt 2016/17 75,000 22,500 8,000 105,500
  2017/18 31,233 9,370 6,000 46,603
Dr.-Ing. Ernst J. Wortberg 2016/17 75,000 37,500 11,000 123,500
  2017/18 31,233 15,616 10,000 56,849
Total 2016/17 1,125,000 255,000 113,000 1,493,000
  2017/18 1,125,619 269,383 176,000 1,571,002

The compensation for the Supervisory Board was redefined at the Annual General Meeting with effect from October 1, 2015 and is governed by Section 12 of Aurubis AG’s Articles of Association. It is oriented towards the various demands of the Supervisory Board and its committees.

All Supervisory Board members receive fixed compensation of € 75,000 per fiscal year each, in addition to the reimbursement of expenses incurred while performing their duties. The Supervisory Board Chairman receives three times, the Deputy Chairman two times that amount.

Supervisory Board members who serve on the Personnel and/or Audit Committee additionally receive fixed compensation of € 15,000 per fiscal year per committee. Supervisory Board members who serve on the other Supervisory Board committees additionally receive fixed compensation of € 7,500 per fiscal year per committee. Supervisory Board members who chair a Supervisory Board committee receive twice that amount per fiscal year for each committee chairmanship.

The fixed compensation for committee activity is limited to € 25,000 per fiscal year for each Supervisory Board member, in accordance with Section 12 (2) of the Articles of Association. The limit for every committee chairmanship is € 50,000 per fiscal year.

Supervisory Board members who do not belong to the Supervisory Board or one of its committees for a full fiscal year receive compensation commensurate with the duration of their service.

Furthermore, Supervisory Board members receive an attendance fee of € 1,000 for each meeting of the Supervisory Board and of its committees attended.

On this basis, the Supervisory Board members received a total of € 1,571,002.  Supervisory Board compensation for fiscal year 2017/18.

Hamburg, December 10, 2018

For the Executive Board 

Jürgen Schachler           Dr. Rainer Verhoeven
Chairman                          Member

 

The Supervisory Board

Prof. Dr. Fritz Vahrenholt
Chairman